282 related articles for article (PubMed ID: 11739563)
1. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease.
Viswanath V; Wu Y; Boonplueang R; Chen S; Stevenson FF; Yantiri F; Yang L; Beal MF; Andersen JK
J Neurosci; 2001 Dec; 21(24):9519-28. PubMed ID: 11739563
[TBL] [Abstract][Full Text] [Related]
2. Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
Turmel H; Hartmann A; Parain K; Douhou A; Srinivasan A; Agid Y; Hirsch EC
Mov Disord; 2001 Mar; 16(2):185-9. PubMed ID: 11295768
[TBL] [Abstract][Full Text] [Related]
3. Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.
Hurelbrink CB; Armstrong RJ; Luheshi LM; Dunnett SB; Rosser AE; Barker RA
Exp Neurol; 2001 Sep; 171(1):46-58. PubMed ID: 11520120
[TBL] [Abstract][Full Text] [Related]
4. Gene disruption of caspase-3 prevents MPTP-induced Parkinson's disease in mice.
Yamada M; Kida K; Amutuhaire W; Ichinose F; Kaneki M
Biochem Biophys Res Commun; 2010 Nov; 402(2):312-8. PubMed ID: 20937256
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
6. A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo.
Yang L; Sugama S; Mischak RP; Kiaei M; Bizat N; Brouillet E; Joh TH; Beal MF
Neurobiol Dis; 2004 Nov; 17(2):250-9. PubMed ID: 15474362
[TBL] [Abstract][Full Text] [Related]
7. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment.
Han BS; Hong HS; Choi WS; Markelonis GJ; Oh TH; Oh YJ
J Neurosci; 2003 Jun; 23(12):5069-78. PubMed ID: 12832530
[TBL] [Abstract][Full Text] [Related]
8. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease.
Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146
[TBL] [Abstract][Full Text] [Related]
9. Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Furuya T; Hayakawa H; Yamada M; Yoshimi K; Hisahara S; Miura M; Mizuno Y; Mochizuki H
J Neurosci; 2004 Feb; 24(8):1865-72. PubMed ID: 14985426
[TBL] [Abstract][Full Text] [Related]
10. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
11. The parkinsonian neurotoxin, MPP+ induces phosphorylated c-Jun in dopaminergric neurons of mesencephalic cultures.
Gearan T; Castillo OA; Schwarzschild MA
Parkinsonism Relat Disord; 2001 Sep; 8(1):19-22. PubMed ID: 11472876
[TBL] [Abstract][Full Text] [Related]
12. Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Karunakaran S; Saeed U; Mishra M; Valli RK; Joshi SD; Meka DP; Seth P; Ravindranath V
J Neurosci; 2008 Nov; 28(47):12500-9. PubMed ID: 19020042
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons.
Choi WS; Eom DS; Han BS; Kim WK; Han BH; Choi EJ; Oh TH; Markelonis GJ; Cho JW; Oh YJ
J Biol Chem; 2004 May; 279(19):20451-60. PubMed ID: 14993216
[TBL] [Abstract][Full Text] [Related]
14. c-IAP1 blocks TNFalpha-mediated cytotoxicity upstream of caspase-dependent and -independent mitochondrial events in human leukemic cells.
Partheniou F; Kelsey SM; Srinivasula SM; Newland AC; Alnemri ES; Jia L
Biochem Biophys Res Commun; 2001 Sep; 287(1):181-9. PubMed ID: 11549272
[TBL] [Abstract][Full Text] [Related]
15. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.
Ghosh A; Saminathan H; Kanthasamy A; Anantharam V; Jin H; Sondarva G; Harischandra DS; Qian Z; Rana A; Kanthasamy AG
J Biol Chem; 2013 Jul; 288(30):21955-71. PubMed ID: 23754278
[TBL] [Abstract][Full Text] [Related]
16. Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration.
Kaul S; Kanthasamy A; Kitazawa M; Anantharam V; Kanthasamy AG
Eur J Neurosci; 2003 Sep; 18(6):1387-401. PubMed ID: 14511319
[TBL] [Abstract][Full Text] [Related]
17. Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release.
Slee EA; Keogh SA; Martin SJ
Cell Death Differ; 2000 Jun; 7(6):556-65. PubMed ID: 10822279
[TBL] [Abstract][Full Text] [Related]
18. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats.
Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G
Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221
[TBL] [Abstract][Full Text] [Related]
19. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Eberhardt O; Coelln RV; Kugler S; Lindenau J; Rathke-Hartlieb S; Gerhardt E; Haid S; Isenmann S; Gravel C; Srinivasan A; Bahr M; Weller M; Dichgans J; Schulz JB
J Neurosci; 2000 Dec; 20(24):9126-34. PubMed ID: 11124990
[TBL] [Abstract][Full Text] [Related]
20. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
Bilsland J; Roy S; Xanthoudakis S; Nicholson DW; Han Y; Grimm E; Hefti F; Harper SJ
J Neurosci; 2002 Apr; 22(7):2637-49. PubMed ID: 11923429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
